Premier Alternatives

Elixirgen Therapeutics

Baltimore, MD · Founded 2012 · Privately Held (backing)

Developer of stem cell therapies designed for treating syndrome and Alzheimer's diseases through regenerative and rejuvenating medicines. Elixirgen Therapeutics is based in Baltimore, MD and was founded in 2012. Its last reported valuation was $67 million in Nov 2023. It has raised $29.1 million across 8 recorded rounds; the latest was a $4 million seed round in Oct 2025.

Last reported valuation
$67.0M
Nov 2026
Priced at
—
Total raised
$29.1M
Last round
Seed Round
Oct 2025
How much has Elixirgen Therapeutics raised?
$29.1Macross 8 recorded rounds · Feb 2021 – Oct 2025

Most recently, Elixirgen Therapeutics raised $4.0M in its Seed Round (Oct 2025).

Elixirgen Therapeutics round by round

8 rounds
Oct 2025Seed Round$4.0MSEC filing▮
1 investors participated
Mar 2025Seed Round$3.6MSEC filing▮
2 investors participated
Jan 2025Seed Round$600KSEC filing▮
2 investors participated
Nov 2023Early Stage VC$7.0MSEC filing▮
1 investors participated
Sep 2022Debt$5.0MSEC filing▮
1 investors participated
Feb 2021Seed Round$4.2MSEC filing▮
2 investors participated
+ 2 earlier rounds · a free Private Market View account shows the full history

How much has Elixirgen Therapeutics raised?

Elixirgen Therapeutics has raised $29.1 million across 8 recorded rounds since 2018. The largest was a $7 million early-stage round in Nov 2023; the most recent was a $4 million seed round in Oct 2025.

Elixirgen Therapeutics has filed 9 Form Ds with the SEC since 2018, most recently in Nov 2025 ($4 million sold to 1 investor).

Elixirgen Therapeutics investors

2 investors are on record for Elixirgen Therapeutics, including The University of Tokyo Edge Capital and Sunovion Pharmaceuticals. The seed round in Oct 2025 drew 1 investor.

For fundraisers
Raising for a company like Elixirgen Therapeutics?

2 investors have backed Elixirgen Therapeutics.

See all 2 investors →

Frequently asked about Elixirgen Therapeutics

How much has Elixirgen Therapeutics raised?
Elixirgen Therapeutics has raised $29.1M in total across 8 recorded funding rounds.
When was Elixirgen Therapeutics's last funding round?
Elixirgen Therapeutics's most recent recorded round was Seed Round in Oct 2025, raising $4.0M.